Our People
SCOTT GRIFFITH
JESSE SHELMIRE
PRESTON GRAHAM
DAVE STORMS, CFA
ZACH AMREIN
JUSTIN MARTIN
QUENTIN HARRAH
LAURA ENGEL, CPA
BEN DOSSETT
ROBERT LYNCH
ROBIN AGIR
BOLTON CORWIN
PAUL WHITLEY
CHRIS GAUVIN
TABER WETZ
LOUISE SHELMIRE
TOM BAKER
Savannah Beaver
AN TRAN SHELMIRE
SCOTT GRIFFITH
Co-CEO, Partner
Stonegate Capital Partners
Scott joined Stonegate in 1992 and is a co-owner of Stonegate. Prior to joining Stonegate, Scott was a Vice-President at Donaldson, Lufkin, & Jenrette from 1980 to 1988 and a Vice-President at Smith Barney from 1988 to 1992. He received his Bachelor of Science in Marketing from Florida State University in 1979. Scott is licensed with Stonegate Capital Markets and currently holds FINRA Series 7, 14, 24, 63, 79, 99 licenses.
JESSE SHELMIRE
Co-CEO, Partner
Stonegate Capital Partners
Jesse is Co-CEO/Partner of Stonegate Capital Partners/Stonegate Capital Markets(Member FINRA/SIPC), and a Co-Founder of Stonegate Healthcare Partners. Jesse spent the first decade of his investment career in 1981 at Smith Barney in retail sales and then later at Jefferies in institutional sales. In the mid-90’s, Jesse was the Managing Director of Investment Banking for First London Securities where he managed public and private transactions. In 1999, Jesse joined Stonegate where he’s managed ~100 transactions and currently provides advisory services for both public and private companies with a focus on healthcare. Jesse received his Bachelor of Science in Economics in 1979 from The Wharton School of Business at the University of Pennsylvania. Jesse is licensed with Stonegate Capital Markets and currently holds FINRA Series 7,24, 63, 79, 99 licenses.
PRESTON GRAHAM
Partner
Stonegate Capital Partners
Preston is the Head of Institutional Sales. He joined Stonegate in 2010. His primary responsibilities involve managing the sales desk, overseeing our institutional outreach effort, and advising issuers on capital markets strategy. Preston was previously with Howard Financial Services in Dallas. He graduated from Santa Clara University with a degree in finance. Preston is licensed with Stonegate Capital Markets, Inc. and currently holds FINRA Series 7, 63, 79, and 99 licenses.
DAVE STORMS, CFA
Director of Research
Stonegate Capital Partners
Dave joined Stonegate in 2022. He was most recently an equity research analyst at Goldman Sachs. He was formerly a Senior investment analyst at Beneficial Financial Group, an analyst at Valuation Research Corporation, and an investment analyst with The Board of Pensions (PCUSA) focused on public equities. He started his career at Vanguard after receiving his undergraduate degree from Rowan University and a Masters in investment management from Temple University. David is licensed with Stonegate Capital Partners and currently holds FINRA Series SIE, 7, 87.
ZACH AMREIN
Head of
Business Development, CCO & CFO
Zach is the Head of business development, Chief Compliance Officer, and our CFO. He joined Stonegate in 2016. He formerly worked in Finance at Legacy Housing. He graduated from the University of Kansas with degrees in Finance and Accounting. Zach is licensed with Stonegate Capital Markets, Inc. and currently holds FINRA Series 7, 24, and 27 licenses.
SAVANNAH BEAVER
Savannah is a public relations and corporate communications professional with five years of experience in the healthcare, biotech, and technology sectors. With expertise in business intelligence monitoring, she leverages data-driven insights to enhance brand visibility and foster trust in the industry. Savannah graduated from Utica University with a degree in Business Communications
JUSTIN MARTIN
Managing Director,
Institutional Sales & ESG Advisory
Justin is a managing director and helps lead the institutional sales effort. He also advises issuers on ESG rating policies and best practices. He joined Stonegate in 2012 and graduated from Auburn University with a Bachelor of Science in Finance. Justin is licensed with Stonegate Capital Markets, Inc. and currently holds FINRA Series 7, 63, and 79 licenses.
LAURA ENGEL, CPA
Senior Advisor,
Research
Laura joined Stonegate in 2011. Her background spans over 20 years in financial services, having held diverse roles in public and private accounting, consulting, and executive leadership. She has broad industry experience within the healthcare, medical technology, and private equity sectors among others, partnering with high-growth organizations as a senior financial officer and consultant. She graduated from the University of Virginia and is a Certified Public Accountant (CPA).
EROL GIRGIN
VP, Institutional Sales
Erol is a Vice President. He Joined Stonegate in 2021. He graduated from Texas Christian University with a Bachelor of Science in economics, and a minor in business. He is currently an MBA Candidate at the University of the Cumberlands.
ROBERT LYNCH
Associate, Institutional Sales & Research
Robert joined Stonegate in 2024. He graduated from Southern Methodist University with a Bachelor of Economics with Finance Applications, and minors in French and Advertising.
QUENTIN HARRAH
VP, Institutional Sales
Quentin is a Vice President. He joined Stonegate in 2021. He graduated from Louisiana State University with degrees in marketing and professional sales.
BEN DOSSETT
Vice President, Institutional Sales
Ben is a Vice President. He joined Stonegate in 2022. He graduated from the University of Alabama with a Bachelor of Science in general business with a sales certificate. He was formerly with Liberty Mutual Insurance.
ROBIN AGIR
Associate, Institutional Sales
Robin is an institutional sales associate. He joined Stonegate in 2022. He was formerly with SRG Capital Partners. He graduated from The University of North Texas with a degree in marketing and communications.
TOM BAKER
Senior Advisor, IR & Communications
Tom is the CEO and cofounder of Reportable, a corporate communications and competitive intelligence software and service. Reportable is helping companies across all industries ranging from top venture-backed startups to publicly traded Fortune 500 companies. Tom has more than 20 years of experience working in corporate communications and investor relations for biotech and medical device companies. Tom graduated UCSD with a B.S. in Pharmacological Chemistry. An avid surfer, Tom grew up in San Diego and currently lives in the Boston area with his wife Melissa and 3 young boys.
DENNIS DOBSON
Managing Director, PR Outreach
Dennis has been a member of the healthcare and technology Public Relations and Investor Relations community for more than three decades and has developed results-oriented programs for a variety of healthcare and technology companies. He has managed highly successful media outreach programs including product launches and financial communications for biotechnology, digital technology, pharmaceutical, medical device, and healthcare services businesses at all stages of their lifecycles. His marketing communications, corporate identity and related brand-development activities have enabled him to serve as a private consultant to start-up and early-stage life science companies. Dennis has a master’s degree in Media Studies from The New School For Social Research in New York City, and a BA from The City University of New York, Baruch College.
ALAMGIR SINGH KANDHARI
Research Analyst
Stonegate Healthcare
Alamgir is a Research Analyst at Stonegate Healthcare and has a BA in Biology from UC Santa Cruz and a Master of Biotechnology & Stem Cell Science from San Jose State University. At UCSC, Alamgir did research in the Sanford Lab to better understand aberrant pre-mRNA splicing mechanisms causing genetic diseases. At BioMarin Pharmaceuticals, he ran cell culture and protein purification GMP production processes. Prior to his role at Stonegate, Alamgir worked at Notable labs, an immuno-oncology company, to develop the ex-vivo assay platform allowing Notable to target Leukemia Stem Cells in AML. He has experience in scientific writing, presenting, experimental, GMP production, and project management. Concurrently he is leading business development at BioRamon Pharmaceuticals to in license and develop oncology drugs.
LOUISE SHELMIRE
Compliance Advisor
Louise has been employed at Stonegate Capital Markets since 2018 as an independent contractor for compliance functions. Louise was previously with Tradestar Investments and Stockcross Financial Services. She has served as a Sales manager and Compliance Principal. Louise graduated with a BA from Louisiana State University. She currently holds FINRA Series 7, 63, 24, 53, 4, 65 and 9/10 licenses and is currently on a roster available to serve as a FINRA arbitrator.
PAUL WHITLEY
Strategic Advisor, Stonegate Inc.
Managing Member CFO / COO / CRO
C‐Suite Support Inc.
Paul is a strategic Fractional CFO and Transformational Technology Leader. He joined Stonegate Capital Partners in 2024. His primary responsibilities include driving business growth through financial, operational, and digital transformation initiatives, as well as implementing quality of earnings assessments, preparing Confidential Information Memorandums (CIM), and providing valuation methodologies. Paul previously held senior roles in various high-profile companies, including Senior VP at a $2 billion hedge fund and CFO/COO at a $180 million public company. He earned his MBA in Internet Technology and E-Commerce from the University of Dallas and a BBA in Finance/Accounting from the University of North Texas. Paul is also known for his extensive experience in growing and sustaining shareholder value, system implementations, and mergers and acquisitions.
BOLTON CORWIN
Analyst, M&A Group
Bolton joined Stonegate in 2024. He attended the University of Oklahoma and studied in the school of Business. Bolton works with the Stonegate’s M&A group, interacting with private equity firms and family offices on Stonegate’s buy-side and sell-side transactional business.
CHRIS GAUVIN
M&A Due Diligence
Chris is a strategic finance executive with extensive experience in accounting, finance, information systems, and strategy. He specializes in helping small and medium-sized companies grow by clarifying strategic vision and creating scalable processes. Chris has held senior roles such as Divisional CFO for a $200 million P&L, VP of Finance at a healthcare startup, and Director of M&A for a $1.5 billion public entity. He earned his Master of Accounting from The University of Texas at Austin and a BBA from Carleton University in Ottawa, Canada. Chris has led financial planning models for companies scaling rapidly, managed over 250 business valuation and due diligence transactions, and spearheaded strategic planning processes for entities with revenues exceeding $1 billion.
TABER WETZ
M&A Due Diligence
Taber is a seasoned finance executive with relevant experience in corporate finance, mergers and acquisitions (M&A), and system implementations. He specializes in helping small and midsize companies grow by developing actionable recommendations for operational improvement. Taber has held senior roles such as CFO and COO for public companies ranging from $1 million to $100 million, and President of a merchant bank that raised over $75 million for an alternative energy startup. He earned his BS in Finance/Accounting from Oklahoma State University. Additionally, Taber has led four reverse mergers into public markets, developed and raised over $75 million in seasoned offerings, and successfully implemented POS and accounting systems for multiple companies. His expertise includes financial planning, risk management, and business development, driving significant growth and operational efficiency.
Securities offered through Stonegate Capital Markets, Inc. (Member FINRA – SIPC)